The authors of “Urticaria Heralding Breast Cancer: Case Report and Literature Review” noticed that the original publication contained an error.
The sentence:
“On December 4, 2020, Reactine 40 mg by mouth daily was added with mild improvement in her symptoms but was later discontinued in September 2019 because of fatigue” is now corrected to “On December 4, 2020, Reactine 40 mg by mouth daily was added with mild improvement in her symptoms but was later discontinued in September 2021 because of fatigue.”
The publisher apologizes for the error. The article has been corrected online and can be accessed at 10.1016/j.adro.2023.101433.